ReviewFrontiers in pharmacology2026

The effect of PCSK9 inhibitors on cardiovascular outcomes in diabetic patients: a narrative review.

Abu-Baker Khalid Sharafeldin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.